Lead Plaintiff Deadline: January 18, 2022
See If You Qualify For Monetary Reward
Please Upload related files below
Fill in below.
Looking for more?
(1) Owlet was reasonably likely to be required to obtain marketing authorization for the Smart Sock because the Food and Drug Administration concluded it was a medical device; (2) as a result, Owlet was reasonably likely to cease commercial distribution of the Smart Sock in the U.S. until it obtained the requisite approval; and (3) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
In order to be included in the lawsuit, you must have incurred a loss on shares of Owlet, Inc. purchased or acquired during the class period listed above.
If you suffered a loss in Owlet, Inc. during the relevant time frame, you have until January 18, 2022 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.